CGEN
CGEN
NASDAQ · Biotechnology

Compugen Ltd

$2.20
+0.07 (+3.29%)
As of Apr 1, 10:08 PM ET ·
Financial Highlights (FY 2026)
Revenue
74.59M
Net Income
36.23M
Gross Margin
87.3%
Profit Margin
48.6%
Rev Growth
+113.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 87.3% 67.8% 67.8% 67.8%
Operating Margin 43.0% 23.0% 25.1% 22.8%
Profit Margin 48.6% 19.8% 24.2% 26.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 74.59M 14.58M 13.34M 13.91M
Gross Profit 65.11M 9.89M 9.05M 9.44M
Operating Income 32.11M 3.36M 3.34M 3.17M
Net Income 36.23M 2.88M 3.22M 3.61M
Gross Margin 87.3% 67.8% 67.8% 67.8%
Operating Margin 43.0% 23.0% 25.1% 22.8%
Profit Margin 48.6% 19.8% 24.2% 26.0%
Rev Growth +113.3% -8.4% -7.1% -8.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 49.00M 44.00M 47.56M
Total Equity 75.78M 75.57M 70.88M
D/E Ratio 0.65 0.58 0.67
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 33.08M 4.55M 4.43M 4.67M
Free Cash Flow 4.06M 3.77M 3.36M